Table 8. Follow-up time by treatment.
Follow-up (days) | VKA ( N = 3,043) | DOAC ( N = 4,991) | Total ( N = 8,034) |
---|---|---|---|
Mean (SD) | 257.4 (122.7) | 252.7 (123.9) | 254.5 (123.4) |
Median (Q1,Q3) | 355.0 (176.0, 365.0) | 344.0 (141.5, 365.0) | 346.0 (157.0, 365.0) |
Min–Max | 1.0–365.0 | 1.0–365.0 | 1.0–365.0 |
Missing | 0 | 0 | 0 |
Abbreviations: DOAC, direct oral anticoagulants; VKA, vitamin K antagonist.